CME Group Inc.

Informe acción NasdaqGS:CME

Capitalización de mercado: US$91.3b

CME Group Dirección

Dirección controles de criterios 3/4

El CEO de CME Group es Terry Duffy , nombrado en Nov 2016, tiene una permanencia de 9.58 años. compensación anual total es $23.39M, compuesta por 8.5% salario y 91.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.015% de las acciones de la empresa, por valor de $14.02M. La antigüedad media del equipo directivo y de la junta directiva es de 9.6 años y 18 años, respectivamente.

Información clave

Terry Duffy

Chief Executive Officer (CEO)

US$23.4m

Compensación total

Porcentaje del salario del CEO8.55%
Permanencia del CEO9.6yrs
Participación del CEO0.02%
Permanencia media de la dirección9.6yrs
Promedio de permanencia en la Junta Directiva18yrs

Actualizaciones recientes de la dirección

Recent updates

Actualización de narrativa Jun 05

CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power

Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.
Actualización de narrativa May 15

CME: Mixed Street Views And New Markets Will Shape Future Earnings Power

Narrative Update on CME Group The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.
Actualización de narrativa Apr 27

CME: Volatile Street Views And New Futures Will Shape Trading Mix

Analysts have nudged their fair value estimate for CME Group down to $308.20 from $311.67, reflecting slightly softer revenue growth assumptions and a higher discount rate, partly balanced by a higher projected profit margin and a modestly lower future P/E, in line with the mix of recent price target trims and increases across the Street. Analyst Commentary Recent Street research on CME Group has been active on both sides, with several firms adjusting price targets and ratings in different directions.
Seeking Alpha Apr 23

CME Group Q1 Earnings Show Strength, But The Stock Still Looks Expensive

Summary CME Group delivered record Q1 volumes and revenue but missed consensus EPS and revenue estimates by narrow margins. CME remains a hold; the stock’s premium valuation already prices in strong volumes, steady cash flows, and its competitive moat. Growth is driven by diverse product expansion, including commodities, crypto, and cross-margining, but near-term upside is limited absent a volatility or trading surge. Key risks are volume normalization, regulatory changes, and tech disruptions; current price fairly reflects both strengths and risks. Read the full article on Seeking Alpha
Actualización de narrativa Apr 11

CME: Volatility And New Contracts Will Shape Rare Earths And Crypto Volumes

The updated analyst price target for CME Group has moved higher by about $5 to $311.67. This change reflects analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a marginally higher future P/E multiple, even as they factor in a small trim to projected profit margins.
Actualización de narrativa Mar 26

CME: Volatility And New Contracts Will Shape Rare Earths And Volume Mix

Analysts have made a modest upward adjustment to the CME Group fair value estimate to about $307 from roughly $305, reflecting slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E following a mix of recent rating changes and price target tweaks across the Street. Analyst Commentary Recent research on CME Group reflects a mixed but generally balanced backdrop, with several firms adjusting ratings and price targets in different directions.
Actualización de narrativa Mar 11

CME: Volatility And New Contracts Will Shape Rare Earths And Clearing Outlook

Our analyst price target for CME Group has moved modestly higher to $305.21 from $299.29, as analysts factor in slightly stronger modeled revenue growth and profitability. This is partially offset by a more conservative future P/E assumption and mixed views on volume drivers across product lines.
Actualización de narrativa Feb 25

CME: Volatility And New Contracts Will Shape Futures And Clearing Outlook

The analyst price target for CME Group edges higher to $232, with recent updates reflecting analysts' focus on firmer commodities volumes, as well as a more expense conscious outlook in their refreshed earnings models. Analyst Commentary Recent Street research around CME Group reflects a mix of optimism on volumes and earnings power, alongside caution on valuation and the cost base.
Actualización de narrativa Feb 10

CME: Volatility And Prediction Markets Will Guide Futures And Clearing Expansion Outlook

The updated analyst price target for CME Group edges higher to about US$297 from roughly US$290, reflecting analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a similar future P/E multiple despite a slightly lower profit margin input. Analyst Commentary Street research on CME Group in recent sessions centers on a cluster of revised price targets and at least one rating change, with several bullish analysts lifting their targets by varying dollar amounts and one major bank fine tuning its view in both directions over a short time frame.
Actualización de narrativa Jan 27

CME: Volatility And Prediction Markets Will Shape Futures Activity Outlook

The analyst price target for CME Group is now US$290.40, a move of about US$2 from the prior US$288.33, as analysts factor in slightly different assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following mixed recent research that includes both a modest target cut and an upgrade linked to a tilt toward volatility. Analyst Commentary Recent research on CME Group reflects a mix of optimism and caution, with one firm trimming its price target slightly and another upgrading the stock on what it sees as a better setup for volatility related trading activity.
Actualización de narrativa Jan 12

CME: Fee Moat And Prediction Markets Will Shape Futures Activity Outlook

Narrative Update: CME Group CME Group's fair value estimate has edged up by about $1 to roughly $288 per share, as analysts cite the company's strong futures and options moat, a higher price target range of up to $314, and interest in its role within prediction markets as key supports for the updated outlook. Analyst Commentary Recent Street research has been generally constructive on CME Group, with several bullish analysts adjusting their price targets higher and highlighting the company's futures and options franchise as a key support for valuation.
Actualización de narrativa Dec 27

CME: Fee Resilience And Prediction Markets Will Balance Lower Volatility Risks

Analysts have nudged their average price target on CME Group modestly higher, to approximately $287 from about $286, citing the company’s resilient fee-based revenue mix, strong competitive moat in futures and options, and supportive demand signals from prediction market partnerships despite some conflicting views on near term volume volatility. Analyst Commentary Recent Street research presents a mixed but generally constructive view on CME Group, with upward moves in price targets tempered by concerns around volume sensitivity and valuation risk if volatility normalizes.
Actualización de narrativa Dec 13

CME: Fee Resilience And New Prediction Markets Will Help Navigate Volatility

Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street. Analyst Commentary Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.
Actualización de narrativa Nov 16

CME: Revenue Resilience And New Ventures Will Balance Volatility Risks Ahead

The average analyst price target for CME Group was raised by approximately $3 to $285, as analysts point to the firm's resilient revenue streams and strong market position amid continued macroeconomic uncertainty. Analyst Commentary Recent analyst activity reflects a mix of optimism and caution regarding CME Group's performance and outlook, particularly as the firm navigates shifting macroeconomic and market conditions.
Seeking Alpha Apr 27

CME: More Market Volatility Equals More Demands - Initiating With Strong Buy

Summary Initiating a 'Strong Buy' rating for CME with a fair value of $301 per share due to increased demand for hedging amid economic uncertainty and market volatility. CME's diverse product offerings and strong trading volume growth, particularly in interest rate options/futures, equity, FX, energy, and commodities, support its robust business model. CME's high operating margin, capex-light business model, and strategic use of Google Cloud enhance profitability and operational efficiency. Key risks include potential pushback on market data price increases and competition from FMX Futures Exchange in the US treasury market. Read the full article on Seeking Alpha
Seeking Alpha Mar 27

CME Group At A New All-Time High - Valuation Concerns Justified?

Summary CME shares have delivered market-beating returns over the past two years, prompting the question of whether it's time to lock in profits. In this update, I discuss whether the rally appears sustainable against the backdrop of the 2024 results published in mid-February. The analysis focuses on average contract volumes and rates, signs of potential underinvestment given the surprisingly strong free cash flow, and includes an update on debt and leverage. I explain why I do not intend to sell my CME stock position despite the elevated valuation, and why I am not even considering a covered call strategy at this time. Read the full article on Seeking Alpha
Seeking Alpha Feb 18

CME Group: High Quality With Good Dividend Yield

Summary CME Group's near-monopoly in futures and options trading, with extraordinary 60% FCF margins, makes it a high-quality, capital-light business despite regulatory costs. Significant acquisitions like CBOT, NYMEX, and KCBT have solidified CME's market dominance, though future focus will be on dividends and smaller acquisitions. CME is slightly undervalued with a 4% dividend yield, making it a strong hold for dividend-focused investors seeking a high-quality business model. Read the full article on Seeking Alpha

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Terry Duffy en comparación con los beneficios de CME Group?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2026n/an/a

US$4b

Dec 31 2025US$23mUS$2m

US$4b

Sep 30 2025n/an/a

US$4b

Jun 30 2025n/an/a

US$4b

Mar 31 2025n/an/a

US$4b

Dec 31 2024US$24mUS$2m

US$3b

Sep 30 2024n/an/a

US$3b

Jun 30 2024n/an/a

US$3b

Mar 31 2024n/an/a

US$3b

Dec 31 2023US$23mUS$2m

US$3b

Sep 30 2023n/an/a

US$3b

Jun 30 2023n/an/a

US$3b

Mar 31 2023n/an/a

US$3b

Dec 31 2022US$23mUS$2m

US$3b

Sep 30 2022n/an/a

US$3b

Jun 30 2022n/an/a

US$3b

Mar 31 2022n/an/a

US$3b

Dec 31 2021US$23mUS$2m

US$3b

Sep 30 2021n/an/a

US$2b

Jun 30 2021n/an/a

US$2b

Mar 31 2021n/an/a

US$2b

Dec 31 2020US$16mUS$2m

US$2b

Sep 30 2020n/an/a

US$2b

Jun 30 2020n/an/a

US$2b

Mar 31 2020n/an/a

US$2b

Dec 31 2019US$12mUS$2m

US$2b

Compensación vs. Mercado: La compensación total de Terry($USD23.39M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD14.81M).

Compensación vs. Ingresos: La compensación de Terry ha sido consistente con los resultados de la empresa en el último año.


CEO

Terry Duffy (68 yo)

9.6yrs
Permanencia
US$23,394,854
Compensación

Mr. Terrence A. Duffy, also known as Terry, has been Chief Executive Officer and Chairman at CME Group, the world’s leading derivatives marketplace since November 15, 2016. Mr. Duffy is the Chief Executive...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Terrence Duffy
Chairman & CEO9.6yrsUS$23.39m0.015%
$ 14.0m
Lynne Fitzpatrick
President & CFO3.2yrsUS$4.75m0.0066%
$ 6.0m
Sunil Cutinho
Chief Information Officer4.3yrsUS$3.38m0.0065%
$ 5.9m
Derek Sammann
Senior MD & Global Head of Commodities Markets16.7yrsUS$3.39m0.0086%
$ 7.9m
Julie Winkler
Senior MD & Chief Commercial Officer19.4yrsUS$3.38m0.0083%
$ 7.6m
Suzanne Sprague
Senior MD1.6yrssin datos0.0038%
$ 3.5m
Jack Tobin
MD & Chief Accounting Officer11.3yrssin datos0.0070%
$ 6.4m
Adam Minick
Investor Contactno datasin datossin datos
Jonathan Marcus
Senior MD & General Counsel3.7yrssin datos0.0020%
$ 1.8m
Anita Liskey
Senior Managing Director of Corporate Marketing & Communications19.3yrssin datossin datos
Hilda Piell
Senior MD & Chief Human Resources Officer18.8yrssin datos0.0076%
$ 7.0m
Kendal Vroman
Chief Transformation Officer6.4yrssin datos0.0052%
$ 4.7m
9.6yrs
Permanencia media
58yo
Promedio de edad

Equipo directivo experimentado: El equipo directivo de CME es experimentado (9.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Terrence Duffy
Chairman & CEO31.4yrsUS$23.39m0.015%
$ 14.0m
Dennis Suskind
Independent Director17.8yrsUS$335.67k0.00074%
$ 675.8k
Martin Gepsman
Independent Director32.4yrsUS$288.50k0.0069%
$ 6.3m
William Shepard
Independent Director29.4yrsUS$311.25k0.072%
$ 66.2m
Howard Siegel
Independent Director26.4yrsUS$301.25k0.019%
$ 17.6m
Bryan Durkin
Independent Director6.1yrsUS$269.25k0.012%
$ 10.8m
Charles Carey
Independent Director18.9yrsUS$337.84k0.0016%
$ 1.5m
Timothy Bitsberger
Independent Director18.1yrsUS$316.25k0.0031%
$ 2.8m
William Hobert
Independent Director8.1yrsUS$312.25k0.035%
$ 31.9m
Daniel Kaye
Independent Director7.1yrsUS$301.25k0.0012%
$ 1.1m
Phyllis Lockett
Independent Director7.1yrsUS$313.25k0.0010%
$ 913.3k
Rahael Seifu
Independent Director6.1yrsUS$292.84k0.0011%
$ 1.0m
18.0yrs
Permanencia media
68.5yo
Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de CME son experimentados ( 18 años antigüedad media).


Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/06/09 04:41
Precio de las acciones al final del día2026/06/09 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

CME Group Inc. está cubierta por 32 analistas. 13 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Stephen BiggarArgus Research Company
Benjamin BudishBarclays
Roger FreemanBarclays